Search results
GSK Completes Demerger of Consumer Healthcare Business
Zacks via Yahoo Finance· 2 years agoPost demerger, GSK is set to focus on its Pharmaceuticals and Vaccines businesses. The consumer...
Is GSK Stock Worth Buying Right Now?
Motley Fool· 10 months agoGSK (NYSE: GSK), a global healthcare company, initiated the separation of its consumer healthcare business, Haleon, last year, as part of its ambitious...
GSK Trims Stake On Consumer Business Spin Off, Raises £804M
Benzinga via Yahoo Finance· 1 year agoGSK Plc (NYSE: GSK) sold 240 million shares of its spun-out consumer healthcare group Haleon Plc...
GSK to divest remaining 4.2% stake in Haleon
Pharmaceutical Technology via Yahoo Finance· 3 weeks agoGSK has announced its intention to divest approximately 385 million ordinary shares in consumer healthcare company Haleon. This equates to approximately...
Pharma Stock Roundup: JNJ, NVS Q2 Earnings, GSK Consumer Unit Spin-Off
Zacks via Yahoo Finance· 2 years agoThis week, J&J JNJ set in motion the second-quarter earnings season for the drug and biotech sector...
GSK's Q2 Earnings Beat, Sales Miss, Raises 2022 Guidance
Zacks via Yahoo Finance· 2 years agoGSK's (GSK) revenues benefit from the strong growth in sales across all segments. The company raises...
This Analyst Says GSK Spin-Off Haleon Offers "Best Of Both Consumer Worlds"
Benzinga via Yahoo Finance· 2 years agoCiti group has initiated coverage on GSK plc's (NYSE: GSK) consumer healthcare spin-off Haleon Plc...
GSK Key Drugs & Vaccines Help Stock Outperform Industry YTD
Zacks via Yahoo Finance· 6 months agoStrong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and...
GSK Outperforms Industry on Strength in Key Drugs & Vaccines
Zacks via Yahoo Finance· 2 months agoStrong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and...
GSK's New Drugs and Pipeline Hold the Key to Growth in 2023
Zacks via Yahoo Finance· 1 year agoGSK's specialty products like Dovato, Nucala, Trelegy Ellipta and Shingrix are likely to drive...
